Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FBPYY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,655
Award facts
- Contract value 100% obligated
- $10,655.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $10,655.40 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, a subdermal contraceptive device. This firm fixed-price delivery order was awarded on November 25, 2025, with an ultimate completion date of December 17, 2025, and the products will be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. The Nexplanon implants represent one of numerous delivery orders issued to this contractor for critical pharmaceutical and medical supply products serving military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DR26FBPYY?
SPE2DR26FBPYY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FBPYY worth?
The government has obligated $10,655 on SPE2DR26FBPYY.
Is contract SPE2DR26FBPYY an order under another contract?
Yes. SPE2DR26FBPYY is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBPYY competed?
The extent of competition for SPE2DR26FBPYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award